Thalidomide can reduce refractory gastrointestinal bleeding from gastrointestinal arteriovenous malformation.

Authors

  • Asier Mitxelena Bengoetxea Osakidetza
  • Angela Vallejo Sagaseta de Ilúrdoz

Keywords:

Gastrointestinal arteriovenous malformation, gastrointestinal bleeding, anemia, Thalidomide.

Abstract

Comparing to iron alone Thalidomide can reduce gastrointestinal bleeding (–67%), red blood cell transfusion (–37%), hospitalizations (–54%), and active gastrointestinal bleeding (–46%). Because the number of patients is small further research is needed.

Author Biography

Asier Mitxelena Bengoetxea, Osakidetza

Barne-Medikuntzako medikua Donostia Ospitale Unibertsitarioan

Downloads

Published

2020-12-30

How to Cite

Mitxelena Bengoetxea, A., & Vallejo Sagaseta de Ilúrdoz, A. (2020). Thalidomide can reduce refractory gastrointestinal bleeding from gastrointestinal arteriovenous malformation. Osagaiz: Osasun-Zientzien Aldizkaria, 4(2). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/298

Issue

Vol. 4 No. 2 (2020)

Section

Kritikoki Aztertutako Testuak